PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Perron Institute for Neurological and Translational Science, Perth, WA, 6009, Australia.\', \'Avicena Systems Ltd, West Perth, WA, 6005, Australia.\', \'Telethon Kids Institute, University of Western Australia, Perth, WA, 6009, Australia.\', \'Biodonostia Health Research Institute, Infectious Diseases Area, Osakidetza Basque Health Service, Donostialdea Integrated Health Organization, San Sebastián, Spain.\', \'Lancs Lamp Laboratory, Heatley House, Bowran Street, Preston, PR1 2UX, UK.\', \'University of Western Australia, Perth, WA, 6009, Australia.\', \'Perron Institute for Neurological and Translational Science, Perth, WA, 6009, Australia. sulev.koks@perron.uwa.edu.au.\', \'Centre for Molecular Medicine and Innovative Therapeutics, Murdoch University, Perth, WA, 6150, Australia. sulev.koks@perron.uwa.edu.au.\', \'Prion Ltd, 50410, Tartu, Estonia. sulev.koks@perron.uwa.edu.au.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1038/s41598-022-08263-4
?:doi
?:hasPublicationType
?:journal
  • Scientific reports
is ?:pmid of
?:pmid
?:pmid
  • 35395856
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.533
?:rankingScore_hIndex
  • 122
is ?:relation_isRelatedTo_publication of
?:title
  • Validation of a rapid, saliva-based, and ultra-sensitive SARS-CoV-2 screening system for pandemic-scale infection surveillance.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all